Affordable Access

Cutanous lesions in multiple myeloma.

Authors
Publication Date
Source
PMC
Keywords
  • Research Article
Disciplines
  • Biology
  • Education
  • Medicine

Abstract

Revised 2013 Ann Grace, myeloma survivor Myeloma This publication was supported in part by a grant from A Message From John Walter President and CEO of The Leukemia & Lymphoma Society The Leukemia & Lymphoma Society (LLS) is committed to bringing you the most up-to-date blood cancer information. We know how important it is for you to have an accurate understanding of your diagnosis, treatment and support options. With this knowledge, you can work with members of your oncology team to move forward with the hope of remission and recovery. Our vision is that one day the great majority of people who have been diagnosed with myeloma will be cured or will be able to manage their disease with a good quality of life. We hope that the information in this booklet will help you along your journey. LLS is the world’s largest voluntary health organization dedicated to funding blood cancer research, education and patient services. Since the first funding in 1954, LLS has invested more than $875 million in research specifically targeting blood cancers. We will continue to invest in research for cures and in programs and services that improve the quality of life of people who have myeloma and their families. We wish you well. John Walter President and CEO Myeloma I page 1 Table of Contents 2 Introduction 2 Here to Help 5 About Myeloma 6 Incidence, Causes and Risk Factors 7 Signs and Symptoms 10 Diagnosis 13 Staging 14 Treatment 22 Treatment for Relapsed or Refractory Myeloma 23 Myeloma Complications and Treatment Side Effects 27 Follow-Up Care 28 Research and Clinical Trials 30 Myeloma-Related Diagnoses 32 Normal Blood and Marrow 34 Medical Terms 43 More Information Acknowledgement The Leukemia & Lymphoma Society gratefully acknowledges, for her critical review and important contributions to the material presented in this publication, Melissa Alsina, MD Head, Multiple Myeloma Transplant Program Associate Member

There are no comments yet on this publication. Be the first to share your thoughts.